Everingham & Kerr, Inc. is pleased to announce that Monomer Polymer and Dajac Labs have been acquired by Addison Capital Partners
Feasterville, PA – March 31, 2008
Everingham & Kerr, Inc. announced today that Monomer Polymer and Dajac Labs (“MPD”) have been acquired by Addison Capital Partners with acquisition financing provided by Banyan Mezzanine. Terms of the transaction were not disclosed.
MPD, headquartered in Feasterville, PA, is engaged in the manufacture and distribution of primarily specialty monomers and polymers with established, in some cases proprietary, procedures to synthesize, modify and purify more than 10,000 monomer and polymer products. MPD’s products are synthesized to be the chemical building blocks used by its customers to manufacture performance products in a variety of industrial and commercial markets including, ophthalmic (implantable lenses), dental, adhesives, coatings, water treatment, food & fermentation, pharmaceuticals and oilfield to name a few.
Addison Capital is a private equity investment firm that seeks out partnerships with owners and operators of lower middle market growth companies to provide liquidity, growth capital and management resources to grow and build exceptional enterprises. Stearns Weaver Miller et al. and Proskauer Rose served as legal advisors to Addison Capital.
Everingham & Kerr, Inc. initiated this transaction, acted as financial advisor and negotiated the transaction for Monomer Polymer and Dajac Labs.
For more information on this transaction, please contact Richard Ward at email@example.com or 215-628-8429.
Everingham & Kerr, Inc